Showing results (251-260 of 1,343) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|December 6, 2019
Prospective validation of the International Warfarin Pharmacogenetics Consortium algorithm in high-risk elderly people (VIALE study)Amelia Filippelli, Simona Signoriello, Ciro Bancone, et al.
The Pharmacogenomics Journal|December 11, 2019
Mucinous adenocarcinoma is a pharmacogenomically distinct subtype of colorectal cancerIan S Reynolds, Emer O'Connell, Michael Fichtner, et al.
The Pharmacogenomics Journal|December 11, 2019
Pharmacogenomic phase transition from personalized medicine to patient-centric customized deliveryArun Radhakrishnan, Gowthamarajan Kuppusamy, Sivasankaran Ponnusankar, et al.
The Pharmacogenomics Journal|January 22, 2020
Genetic variants in CYP2A6 and UGT1A9 genes associated with urinary nicotine metabolites in young Mexican smokersGissela Borrego-Soto, Yadira X Perez-Paramo, Gang Chen, et al.
The Pharmacogenomics Journal|July 29, 2015
Genotype-phenotype correlations in 5-fluorouracil metabolism: a candidate DPYD haplotype to improve toxicity predictionG Gentile, A Botticelli, L Lionetto, et al.
The Pharmacogenomics Journal|August 19, 2015
Association studies of genomic variants with treatment response to risperidone, clozapine, quetiapine and chlorpromazine in the Chinese Han populationQ Xu, X Wu, M Li, et al.
The Pharmacogenomics Journal|January 29, 2019
Early modifications of circulating microRNAs levels in metastatic colorectal cancer patients treated with regorafenibMarta Schirripa, Beatrice Borelli, Romina D'Aurizio, et al.
The Pharmacogenomics Journal|February 13, 2019
Precision dosing of warfarin: open questions and strategiesXi Li, Dan Li, Ji-Chu Wu, et al.
The Pharmacogenomics Journal|January 5, 2018
Cost-effectiveness of HLA-DQB1/HLA-B pharmacogenetic-guided treatment and blood monitoring in US patients taking clozapineFrançois R Girardin, Antoine Poncet, Arnaud Perrier, et al.
The Pharmacogenomics Journal|June 2, 2021
Determining the potential clinical value of panel-based pharmacogenetic testing in patients with chronic pain or gastroesophageal reflux diseaseAmanda L Elchynski, Emily J Cicali, Maria C Ferrer Del Busto, et al.
Pageof 135